Copy to clipboard 
Enovis has acquired Insight Medical Systems. Insight’s flagship solution, ARVIS, is reportedly the only FDA-cleared augmented reality solution precisely engineered for the specific needs of hip and knee replacement surgery. Financial terms of the transaction were not disclosed.
“We are excited to welcome Insight’s talented team to our Enovis family where we will work together to improve patient outcomes through the use of next generation augmented reality surgical guidance in orthopedic surgery,” said Matt Trerotola, CEO, Enovis. “Adding Insight’s technology to our rapidly growing Surgical business advances our enabling technologies platform with innovation tailored to today’s healthcare economics, and especially the ASC.”
Since Enovis’ initial investment in Insight Medical Systems in 2020 and a follow-on funding round in 2021, the company received FDA 510(k) clearance for the ARVIS Augmented Reality System and successfully completed over 200 cases in the U.S.
“ARVIS delivers real-time, hands-free surgical guidance at the point of care and is designed to generate measurably better patient outcomes in a streamlined, space-conserving and cost-effective manner compared to traditional robotic offerings,” said Brady Shirley, COO, Enovis. “Simply put, the ARVIS Augmented Reality System represents the next era of orthopedic technology, and we look forward to expanding its features and reach while integrating additional joint replacement surgery capabilities in the future.”
ARVIS will be commercially available in 3Q22, and the Insight team will become part of the Enovis Surgical organization (previously DJO Surgical) with the goal of driving further growth and expansion of the company’s orthopedic enabling technologies platform.
In May, Enovis also acquired Australian orthopedic startup, 360 Med Care. This was the first acquisition since the rebrand of DJO to Enovis.
